(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MLXIPL mRNA] CTD PMID:31150632 (+/-)-Aegeline multiple interactions ISO Mlxipl (Mus musculus) 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of MLXIPL mRNA CTD PMID:28843594 (aminooxy)acetic acid multiple interactions ISO Mlxipl (Mus musculus) 6480464 [Aminooxyacetic Acid co-treated with Xylitol] results in increased expression of MLXIPL mRNA alternative form CTD PMID:31974165 (RS)-coclaurine multiple interactions ISO Mlxipl (Mus musculus) 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of MLXIPL mRNA CTD PMID:28843594 (RS)-norcoclaurine multiple interactions ISO Mlxipl (Mus musculus) 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of MLXIPL mRNA CTD PMID:28843594 (S)-coclaurine multiple interactions ISO Mlxipl (Mus musculus) 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of MLXIPL mRNA CTD PMID:28843594 1,2-dimethylhydrazine decreases expression ISO Mlxipl (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of MLXIPL mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO Mlxipl (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of MLXIPL mRNA CTD PMID:17555576 17alpha-ethynylestradiol decreases expression ISO Mlxipl (Mus musculus) 6480464 Ethinyl Estradiol results in decreased expression of MLXIPL mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO MLXIPL (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of MLXIPL mRNA CTD PMID:30165855 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of MLXIPL mRNA CTD PMID:32145629 and PMID:35192832 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Mlxipl (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of MLXIPL mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO MLXIPL (Homo sapiens) 6480464 [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of MLXIPL mRNA CTD PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Mlxipl (Mus musculus) 6480464 Dietary Fats promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of MLXIPL mRNA] and Tetrachlorodibenzodioxin inhibits the reaction [Dietary Fats results in increased expression of MLXIPL mRNA] CTD PMID:27713108 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Mlxipl (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of MLXIPL mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Mlxipl (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of MLXIPL mRNA CTD PMID:26290441 and PMID:27713108 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO MLXIPL (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MLXIPL mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of MLXIPL mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression ISO Mlxipl (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of MLXIPL mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO MLXIPL (Homo sapiens) 6480464 bisphenol S results in increased expression of MLXIPL mRNA CTD PMID:27685785 4,4'-sulfonyldiphenol decreases methylation ISO Mlxipl (Mus musculus) 6480464 bisphenol S results in decreased methylation of MLXIPL gene CTD PMID:31683443 4,4'-sulfonyldiphenol increases methylation ISO Mlxipl (Mus musculus) 6480464 bisphenol S results in increased methylation of MLXIPL exon CTD PMID:33297965 4-hydroxyphenyl retinamide increases expression ISO Mlxipl (Mus musculus) 6480464 Fenretinide results in increased expression of MLXIPL mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO MLXIPL (Homo sapiens) 6480464 Decitabine affects the expression of MLXIPL mRNA CTD PMID:23300844 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime increases expression ISO MLXIPL (Homo sapiens) 6480464 6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:27180240 and PMID:30611723 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime multiple interactions ISO MLXIPL (Homo sapiens) 6480464 [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:30611723 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of MLXIPL mRNA CTD PMID:30047161 aflatoxin B1 affects expression ISO MLXIPL (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of MLXIPL protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO MLXIPL (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of MLXIPL mRNA CTD PMID:22100608 and PMID:27153756 aflatoxin B1 increases expression ISO Mlxipl (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of MLXIPL mRNA CTD PMID:19770486 aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of MLXIPL protein CTD PMID:16644726 and PMID:16790840 aldehydo-D-glucose increases expression ISO Mlxipl (Mus musculus) 6480464 Glucose results in increased expression of MLXIPL mRNA alternative form CTD PMID:31974165 aldehydo-D-glucose multiple interactions ISO Mlxipl (Mus musculus) 6480464 [Glucose co-treated with S 4048] results in increased expression of MLXIPL mRNA and Glucose promotes the reaction [MLXIPL protein binds to TUG1 promoter] CTD PMID:31974165 and PMID:32467232 amiodarone decreases expression ISO Mlxipl (Mus musculus) 6480464 Amiodarone results in decreased expression of MLXIPL mRNA CTD PMID:28962527 amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of MLXIPL mRNA CTD PMID:30047161 atorvastatin calcium multiple interactions EXP 6480464 Atorvastatin inhibits the reaction [Fructose affects the localization of and results in increased activity of MLXIPL protein] more ... CTD PMID:19053045 and PMID:21122807 atrazine multiple interactions ISO Mlxipl (Mus musculus) 6480464 Atrazine promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of MLXIPL mRNA] CTD PMID:24440342 benzo[a]pyrene affects expression ISO Mlxipl (Mus musculus) 6480464 Benzo(a)pyrene affects the expression of MLXIPL mRNA CTD PMID:22342234 benzo[a]pyrene decreases expression ISO MLXIPL (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of MLXIPL mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO MLXIPL (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of MLXIPL promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO Mlxipl (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of MLXIPL mRNA CTD PMID:19770486 benzo[a]pyrene multiple interactions ISO Mlxipl (Mus musculus) 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to MLXIPL promoter] CTD PMID:19654925 bexarotene multiple interactions ISO MLXIPL (Homo sapiens) 6480464 [Bexarotene co-treated with GW 3965] results in decreased expression of MLXIPL mRNA and [Bexarotene co-treated with T0901317] results in decreased expression of MLXIPL mRNA CTD PMID:32123961 bisphenol A affects expression ISO Mlxipl (Mus musculus) 6480464 bisphenol A affects the expression of MLXIPL mRNA and bisphenol A affects the expression of MLXIPL protein CTD PMID:21932408 bisphenol A increases expression ISO Mlxipl (Mus musculus) 6480464 bisphenol A results in increased expression of MLXIPL mRNA CTD PMID:34585602 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MLXIPL mRNA CTD PMID:32145629 bisphenol A affects expression ISO MLXIPL (Homo sapiens) 6480464 bisphenol A affects the expression of MLXIPL mRNA CTD PMID:30903817 bisphenol A affects methylation ISO Mlxipl (Mus musculus) 6480464 bisphenol A affects the methylation of MLXIPL promoter CTD PMID:27334623 bisphenol A multiple interactions ISO MLXIPL (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MLXIPL mRNA CTD PMID:28628672 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MLXIPL mRNA CTD PMID:25181051 and PMID:35192832 bisphenol A increases expression ISO MLXIPL (Homo sapiens) 6480464 bisphenol A results in increased expression of MLXIPL mRNA CTD PMID:25619500 cadmium atom multiple interactions ISO MLXIPL (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MLXIPL mRNA CTD PMID:35301059 cadmium dichloride increases expression ISO Mlxipl (Mus musculus) 6480464 Cadmium Chloride results in increased expression of MLXIPL mRNA CTD PMID:26352046 cadmium dichloride multiple interactions ISO MLXIPL (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MLXIPL mRNA CTD PMID:35301059 caffeine multiple interactions ISO Mlxipl (Mus musculus) 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of MLXIPL mRNA CTD PMID:28843594 caffeine increases phosphorylation ISO MLXIPL (Homo sapiens) 6480464 Caffeine results in increased phosphorylation of MLXIPL protein CTD PMID:35688186 carbon nanotube decreases expression ISO Mlxipl (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 cetirizine decreases expression ISO Mlxipl (Mus musculus) 6480464 Cetirizine results in decreased expression of MLXIPL mRNA CTD PMID:24852568 cetirizine multiple interactions ISO Mlxipl (Mus musculus) 6480464 APOE gene mutant form inhibits the reaction [Cetirizine results in decreased expression of MLXIPL mRNA] CTD PMID:24852568 CGP 52608 multiple interactions ISO MLXIPL (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to MLXIPL gene] CTD PMID:28238834 chlordecone increases expression ISO Mlxipl (Mus musculus) 6480464 Chlordecone results in increased expression of MLXIPL mRNA CTD PMID:29980752 chlorpyrifos decreases expression ISO Mlxipl (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of MLXIPL mRNA CTD PMID:37019170 cholesterol multiple interactions ISO Mlxipl (Mus musculus) 6480464 [lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of MLXIPL mRNA and Atrazine promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of MLXIPL mRNA] CTD PMID:24440342 choline multiple interactions ISO Mlxipl (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MLXIPL mRNA CTD PMID:22872676 ciguatoxin CTX1B affects expression ISO Mlxipl (Mus musculus) 6480464 Ciguatoxins affects the expression of MLXIPL mRNA CTD PMID:18353800 cisplatin affects expression ISO MLXIPL (Homo sapiens) 6480464 Cisplatin affects the expression of MLXIPL mRNA CTD PMID:23300844 cisplatin increases expression ISO MLXIPL (Homo sapiens) 6480464 Cisplatin results in increased expression of MLXIPL mRNA CTD PMID:27392435 and PMID:27594783 cisplatin multiple interactions ISO MLXIPL (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of MLXIPL mRNA CTD PMID:27392435 copper(II) sulfate decreases expression ISO MLXIPL (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of MLXIPL mRNA CTD PMID:19549813 CU-O LINKAGE increases expression ISO MLXIPL (Homo sapiens) 6480464 cupric oxide results in increased expression of MLXIPL mRNA CTD PMID:22077320 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of MLXIPL mRNA CTD PMID:27523638 cyclosporin A decreases expression ISO MLXIPL (Homo sapiens) 6480464 Cyclosporine results in decreased expression of MLXIPL mRNA CTD PMID:20106945 and PMID:25562108 cyclosporin A decreases methylation ISO MLXIPL (Homo sapiens) 6480464 Cyclosporine results in decreased methylation of MLXIPL promoter CTD PMID:27989131 D-glucose increases expression EXP 6480464 Glucose results in increased expression of MLXIPL protein CTD PMID:16644726 and PMID:16790840 D-glucose increases expression ISO Mlxipl (Mus musculus) 6480464 Glucose results in increased expression of MLXIPL mRNA alternative form CTD PMID:31974165 D-glucose multiple interactions ISO Mlxipl (Mus musculus) 6480464 [Glucose co-treated with S 4048] results in increased expression of MLXIPL mRNA and Glucose promotes the reaction [MLXIPL protein binds to TUG1 promoter] CTD PMID:31974165 and PMID:32467232 dexamethasone increases expression ISO MLXIPL (Homo sapiens) 6480464 Dexamethasone results in increased expression of MLXIPL mRNA CTD PMID:25047013 dexamethasone increases expression ISO Mlxipl (Mus musculus) 6480464 Dexamethasone results in increased expression of MLXIPL mRNA alternative form CTD PMID:31053639 dexamethasone multiple interactions ISO Mlxipl (Mus musculus) 6480464 [ANGPTL4 gene mutant form results in increased susceptibility to Dexamethasone] which results in decreased expression of MLXIPL mRNA and ANGPTL4 gene mutant form inhibits the reaction [Dexamethasone results in decreased expression of MLXIPL mRNA alternative form] CTD PMID:31053639 dexamethasone multiple interactions ISO MLXIPL (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MLXIPL mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of MLXIPL mRNA CTD PMID:28628672 dicrotophos increases expression ISO MLXIPL (Homo sapiens) 6480464 dicrotophos results in increased expression of MLXIPL mRNA CTD PMID:28302478 difenoconazole multiple interactions ISO MLXIPL (Homo sapiens) 6480464 [difenoconazole co-treated with fludioxonil] results in decreased expression of MLXIPL mRNA CTD PMID:33575850 difenoconazole decreases expression ISO Mlxipl (Mus musculus) 6480464 difenoconazole results in decreased expression of MLXIPL mRNA CTD PMID:34425431 dioxygen multiple interactions ISO Mlxipl (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MLXIPL mRNA CTD PMID:30529165 disodium selenite decreases expression ISO Mlxipl (Mus musculus) 6480464 Sodium Selenite results in decreased expression of MLXIPL mRNA CTD PMID:23274088 dorsomorphin multiple interactions ISO MLXIPL (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MLXIPL mRNA CTD PMID:27188386 enilconazole decreases expression ISO MLXIPL (Homo sapiens) 6480464 enilconazole results in decreased expression of MLXIPL mRNA CTD PMID:32201337 entinostat increases expression ISO MLXIPL (Homo sapiens) 6480464 entinostat results in increased expression of MLXIPL mRNA CTD PMID:26272509 entinostat multiple interactions ISO MLXIPL (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MLXIPL mRNA CTD PMID:27188386 ethanol multiple interactions ISO Mlxipl (Mus musculus) 6480464 pirinixic acid inhibits the reaction [Ethanol results in increased expression of MLXIPL mRNA] CTD PMID:18620774 ethanol increases expression EXP 6480464 Ethanol results in increased expression of MLXIPL mRNA and Ethanol results in increased expression of MLXIPL protein CTD PMID:27989594 ethanol multiple interactions EXP 6480464 salvianolic acid B inhibits the reaction [Ethanol results in increased expression of MLXIPL mRNA] more ... CTD PMID:27989594 ethanol increases expression ISO Mlxipl (Mus musculus) 6480464 Ethanol results in increased expression of MLXIPL mRNA CTD PMID:18620774 ethanol increases activity ISO Mlxipl (Mus musculus) 6480464 Ethanol results in increased activity of MLXIPL protein CTD PMID:18620774 farnesol multiple interactions ISO MLXIPL (Homo sapiens) 6480464 [Farnesol analog co-treated with Oleic Acid] results in decreased expression of MLXIPL mRNA CTD PMID:30611723 fenthion decreases expression ISO Mlxipl (Mus musculus) 6480464 Fenthion results in decreased expression of MLXIPL mRNA CTD PMID:34813904 Fexofenadine hydrochloride multiple interactions ISO Mlxipl (Mus musculus) 6480464 APOE gene mutant form inhibits the reaction [fexofenadine results in decreased expression of MLXIPL mRNA] CTD PMID:24852568 Fexofenadine hydrochloride decreases expression ISO Mlxipl (Mus musculus) 6480464 fexofenadine results in decreased expression of MLXIPL mRNA CTD PMID:24852568 fludioxonil multiple interactions ISO MLXIPL (Homo sapiens) 6480464 [difenoconazole co-treated with fludioxonil] results in decreased expression of MLXIPL mRNA and [tebuconazole co-treated with fludioxonil] results in decreased expression of MLXIPL mRNA CTD PMID:33575850 fludioxonil decreases expression ISO MLXIPL (Homo sapiens) 6480464 fludioxonil results in decreased expression of MLXIPL mRNA CTD PMID:33575850 folic acid multiple interactions ISO Mlxipl (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MLXIPL mRNA CTD PMID:22872676 fructose multiple interactions EXP 6480464 Atorvastatin inhibits the reaction [Fructose affects the localization of and results in increased activity of MLXIPL protein] more ... CTD PMID:19053045 and PMID:21122807 fructose decreases expression ISO Mlxipl (Mus musculus) 6480464 Fructose results in decreased expression of MLXIPL mRNA CTD PMID:28123933 fructose increases expression ISO Mlxipl (Mus musculus) 6480464 Fructose results in increased expression of MLXIPL mRNA alternative form CTD PMID:28123933 fructose multiple interactions ISO Mlxipl (Mus musculus) 6480464 FGF21 gene mutant form inhibits the reaction [Fructose results in increased expression of MLXIPL mRNA alternative form] more ... CTD PMID:28123933 fructose increases activity EXP 6480464 Fructose results in increased activity of MLXIPL protein CTD PMID:19799862 fructose increases expression EXP 6480464 Fructose results in increased expression of MLXIPL mRNA and Fructose results in increased expression of MLXIPL protein CTD PMID:18346472 and PMID:21122807 furan decreases expression EXP 6480464 furan results in decreased expression of MLXIPL mRNA CTD PMID:26194646 glucose increases expression EXP 6480464 Glucose results in increased expression of MLXIPL protein CTD PMID:16644726 and PMID:16790840 glucose increases expression ISO Mlxipl (Mus musculus) 6480464 Glucose results in increased expression of MLXIPL mRNA alternative form CTD PMID:31974165 glucose multiple interactions ISO Mlxipl (Mus musculus) 6480464 [Glucose co-treated with S 4048] results in increased expression of MLXIPL mRNA and Glucose promotes the reaction [MLXIPL protein binds to TUG1 promoter] CTD PMID:31974165 and PMID:32467232 glyphosate decreases expression ISO Mlxipl (Mus musculus) 6480464 Glyphosate results in decreased expression of MLXIPL protein CTD PMID:37208198 GW 3965 multiple interactions ISO MLXIPL (Homo sapiens) 6480464 [Bexarotene co-treated with GW 3965] results in decreased expression of MLXIPL mRNA CTD PMID:32123961 GW 3965 decreases expression ISO MLXIPL (Homo sapiens) 6480464 GW 3965 results in decreased expression of MLXIPL mRNA CTD PMID:32123961 GW 4064 decreases expression ISO MLXIPL (Homo sapiens) 6480464 GW 4064 results in decreased expression of MLXIPL mRNA CTD PMID:30611723 GW 4064 multiple interactions ISO MLXIPL (Homo sapiens) 6480464 [GW 4064 co-treated with Oleic Acid] results in decreased expression of MLXIPL mRNA CTD PMID:30611723 GW 7647 multiple interactions ISO MLXIPL (Homo sapiens) 6480464 [GW 7647 co-treated with Oleic Acid] results in decreased expression of MLXIPL mRNA CTD PMID:30611723 indometacin multiple interactions ISO MLXIPL (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MLXIPL mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of MLXIPL mRNA CTD PMID:28628672 irinotecan affects expression EXP 6480464 Irinotecan affects the expression of MLXIPL mRNA CTD PMID:20097248 L-methionine multiple interactions ISO Mlxipl (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MLXIPL mRNA CTD PMID:22872676 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of MLXIPL mRNA CTD PMID:30047161 monosodium L-glutamate decreases expression EXP 6480464 Sodium Glutamate results in decreased expression of MLXIPL mRNA CTD PMID:26092479 monosodium L-glutamate multiple interactions EXP 6480464 Taurine inhibits the reaction [Sodium Glutamate results in decreased expression of MLXIPL mRNA] CTD PMID:26092479 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions EXP 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Atorvastatin inhibits the reaction [Fructose results in increased activity of MLXIPL protein]] CTD PMID:19053045 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of MLXIPL mRNA CTD PMID:24136188 nicotinamide multiple interactions EXP 2326081 nicotinamide inhibits the reaction [5/6 nephrectomy increases the expression of Mlxipl protein in kidney] RGD nicotinic acid decreases expression EXP 6480464 Niacin results in decreased expression of MLXIPL protein CTD PMID:19878707 nordihydroguaiaretic acid decreases expression EXP 329955565 NDGA decreases expression of mRNA in liver of high fructose fed rats RGD oleic acid multiple interactions ISO MLXIPL (Homo sapiens) 6480464 [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:30611723 paracetamol affects expression ISO Mlxipl (Mus musculus) 6480464 Acetaminophen affects the expression of MLXIPL mRNA CTD PMID:17562736 paracetamol decreases expression ISO MLXIPL (Homo sapiens) 6480464 Acetaminophen results in decreased expression of MLXIPL mRNA CTD PMID:26690555 paracetamol decreases expression ISO Mlxipl (Mus musculus) 6480464 Acetaminophen results in decreased expression of MLXIPL mRNA CTD PMID:19420014 paraquat decreases expression ISO MLXIPL (Homo sapiens) 6480464 Paraquat results in decreased expression of MLXIPL mRNA CTD PMID:34681664 paxilline increases expression ISO MLXIPL (Homo sapiens) 6480464 paxilline results in increased expression of MLXIPL mRNA CTD PMID:32123961 perfluorononanoic acid decreases expression ISO MLXIPL (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of MLXIPL mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid decreases expression ISO MLXIPL (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of MLXIPL mRNA CTD PMID:27153767 and PMID:32588087 perfluorooctane-1-sulfonic acid multiple interactions ISO Mlxipl (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of MLXIPL mRNA CTD PMID:36331819 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of MLXIPL mRNA CTD PMID:31324951 pirinixic acid multiple interactions ISO Mlxipl (Mus musculus) 6480464 pirinixic acid inhibits the reaction [Ethanol results in increased expression of MLXIPL mRNA] CTD PMID:18620774 pirinixic acid multiple interactions EXP 6480464 MLXIPL protein inhibits the reaction [pirinixic acid results in decreased expression of PKLR mRNA] CTD PMID:16644726 pirinixic acid decreases expression ISO Mlxipl (Mus musculus) 6480464 pirinixic acid results in decreased expression of MLXIPL mRNA CTD PMID:18445702 propamocarb decreases expression ISO Mlxipl (Mus musculus) 6480464 propamocarb results in decreased expression of MLXIPL mRNA CTD PMID:29137890 propiconazole multiple interactions ISO MLXIPL (Homo sapiens) 6480464 [propiconazole co-treated with tebuconazole] results in increased expression of MLXIPL mRNA CTD PMID:30989312 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of MLXIPL mRNA CTD PMID:28374803 salvianolic acid B multiple interactions EXP 6480464 salvianolic acid B inhibits the reaction [Ethanol results in increased expression of MLXIPL mRNA] more ... CTD PMID:27989594 SB 431542 multiple interactions ISO MLXIPL (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MLXIPL mRNA CTD PMID:27188386 silicon dioxide decreases expression ISO MLXIPL (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of MLXIPL mRNA CTD PMID:25895662 sodium arsenate increases expression ISO Mlxipl (Mus musculus) 6480464 sodium arsenate results in increased expression of MLXIPL mRNA CTD PMID:30953684 sodium arsenite increases expression ISO Mlxipl (Mus musculus) 6480464 sodium arsenite results in increased expression of MLXIPL mRNA CTD PMID:31532247 sucrose multiple interactions ISO Mlxipl (Mus musculus) 6480464 [lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of MLXIPL mRNA and Atrazine promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of MLXIPL mRNA] CTD PMID:24440342 sulforaphane increases expression ISO MLXIPL (Homo sapiens) 6480464 sulforaphane results in increased expression of MLXIPL mRNA CTD PMID:31838189 tamoxifen affects expression ISO Mlxipl (Mus musculus) 6480464 Tamoxifen affects the expression of MLXIPL mRNA CTD PMID:17555576 taurine multiple interactions EXP 6480464 Taurine inhibits the reaction [Sodium Glutamate results in decreased expression of MLXIPL mRNA] CTD PMID:26092479 tebuconazole multiple interactions ISO MLXIPL (Homo sapiens) 6480464 [propiconazole co-treated with tebuconazole] results in increased expression of MLXIPL mRNA and [tebuconazole co-treated with fludioxonil] results in decreased expression of MLXIPL mRNA CTD PMID:30989312 and PMID:33575850 tebuconazole increases expression ISO MLXIPL (Homo sapiens) 6480464 tebuconazole results in increased expression of MLXIPL mRNA CTD PMID:30989312 tetrachloromethane decreases expression ISO Mlxipl (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of MLXIPL mRNA CTD PMID:27339419 and PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MLXIPL mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of MLXIPL mRNA CTD PMID:31150632 thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of MLXIPL protein CTD PMID:35544339 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of MLXIPL mRNA CTD PMID:23411599 and PMID:34492290 triclosan decreases expression ISO MLXIPL (Homo sapiens) 6480464 Triclosan results in decreased expression of MLXIPL mRNA CTD PMID:34681664 tris(2-butoxyethyl) phosphate affects expression ISO MLXIPL (Homo sapiens) 6480464 tris(2-butoxyethyl) phosphate affects the expression of MLXIPL mRNA CTD PMID:29024780 trovafloxacin multiple interactions ISO Mlxipl (Mus musculus) 6480464 [trovafloxacin co-treated with lipopolysaccharide and E coli O55-B5] results in decreased expression of MLXIPL mRNA CTD PMID:18930950 urethane decreases expression ISO MLXIPL (Homo sapiens) 6480464 Urethane results in decreased expression of MLXIPL mRNA CTD PMID:28818685 valproic acid decreases expression ISO MLXIPL (Homo sapiens) 6480464 Valproic Acid results in decreased expression of MLXIPL mRNA CTD PMID:29154799 xylitol multiple interactions ISO Mlxipl (Mus musculus) 6480464 [Aminooxyacetic Acid co-treated with Xylitol] results in increased expression of MLXIPL mRNA alternative form CTD PMID:31974165 xylitol increases expression ISO Mlxipl (Mus musculus) 6480464 Xylitol results in increased expression of MLXIPL mRNA alternative form CTD PMID:31974165 yohimbine multiple interactions ISO Mlxipl (Mus musculus) 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of MLXIPL mRNA CTD PMID:28843594